Progression of Chronic UVB-Induced Skin Damage During Long-Term Topical Nicotinamide Mononucleotide Treatment in Mice
- 1Division of Dermatology, Chulabhorn International College of Medicine, Thammasat University, Khlong Luang 12120, Pathum Thani, Thailand
- 2Department of Pathology, Faculty of Medicine, Thammasat University, Khlong Luang 12120, Pathum Thani, Thailand
Abstract
Nicotinamide mononucleotide (NMN), a precursor of nicotinamide adenine dinucleotide (NAD+), is widely investigated as a potential anti-aging intervention. However, its long-term efficacy and safety, particularly in topical formulations applied to chronically photodamaged skin, remain unclear. This study evaluated whether topical 5% NMN modifies the progression of chronic UVB-induced skin damage in mice. Female C57BL/6NJcl mice were assigned to four groups: non-irradiated control, UVB alone, UVB plus vehicle cream, and UVB plus 5% NMN cream. UVB was delivered to shaved dorsal skin three times weekly at 120 mJ/cm2, and cream was applied after each irradiation through week 25. UVB-exposed groups developed progressive skin damage, with the UVB plus NMN group showing a nonsignificant trend toward greater clinical severity at week 25 (p = 0.08). Histological analysis showed significant increases in epidermal thickness and dysplasia from week 12 to the late endpoint only in the UVB plus NMN group. These changes were accompanied by marked induction of Krt6, Krt16, and S100a8, whereas Krt1 showed no significant change. In contrast, no increase in Parp1 and Sirt1 was observed at the transcriptional level in the NMN group. Parp1 and Sirt1 were significantly upregulated in the UVB alone and UVB plus vehicle groups but not in UVB plus NMN-treated skin. Overall, these findings indicate that long-term topical NMN did not protect chronically UVB-exposed mouse skin and may have contributed to the worsening of photodamage.
Related
- Progression of Chronic Liver Inflammation and Fibrosis Driven by Activation of c-JUN Signaling in Sirt6 Mutant Mice
- Mitochondria as Key Players in Sarcoma Development, Progression and Drug Resistance: From Mechanistic Insights to New Treatment Opportunities
- The Role of METTL3-Mediated m⁶A Methylation in Hepatocellular Carcinoma Progression and Treatment.
- Possible Links Between PM2.5-Induced NLRP3 Inflammasome Activation and Its Role in Lung Cancer Progression and Drug Resistance
- Nicotinamide N-methyltransferase couples inflammation and epigenetic remodelling to hepatic fibrosis
BibTeX
@article{phadungsaksawasdi2026progression,
title = {{Progression of Chronic UVB-Induced Skin Damage During Long-Term Topical Nicotinamide Mononucleotide Treatment in Mice}},
author = {Pawit Phadungsaksawasdi and Kanyawan Harnsiriwattana and Kodchakorn Chukanchitipat and Napat Hunsajarupan and Adiluck Pisutpunya},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27219807},
url = {https://www.mdpi.com/1422-0067/27/21/9807},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Progression of Chronic UVB-Induced Skin Damage During Long-Term Topical Nicotinamide Mononucleotide Treatment in Mice
AU - Pawit Phadungsaksawasdi
AU - Kanyawan Harnsiriwattana
AU - Kodchakorn Chukanchitipat
AU - Napat Hunsajarupan
AU - Adiluck Pisutpunya
PY - 2026
DA - 2026/10/31
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27219807
UR - https://www.mdpi.com/1422-0067/27/21/9807
AB - Nicotinamide mononucleotide (NMN), a precursor of nicotinamide adenine dinucleotide (NAD+), is widely investigated as a potential anti-aging intervention. However, its long-term efficacy and safety, particularly in topical formulations applied to chronically photodamaged skin, remain unclear. This study evaluated whether topical 5% NMN modifies the progression of chronic UVB-induced skin damage in mice. Female C57BL/6NJcl mice were assigned to four groups: non-irradiated control, UVB alone, UVB plus vehicle cream, and UVB plus 5% NMN cream. UVB was delivered to shaved dorsal skin three times weekly at 120 mJ/cm2, and cream was applied after each irradiation through week 25. UVB-exposed groups developed progressive skin damage, with the UVB plus NMN group showing a nonsignificant trend toward greater clinical severity at week 25 (p = 0.08). Histological analysis showed significant increases in epidermal thickness and dysplasia from week 12 to the late endpoint only in the UVB plus NMN group. These changes were accompanied by marked induction of Krt6, Krt16, and S100a8, whereas Krt1 showed no significant change. In contrast, no increase in Parp1 and Sirt1 was observed at the transcriptional level in the NMN group. Parp1 and Sirt1 were significantly upregulated in the UVB alone and UVB plus vehicle groups but not in UVB plus NMN-treated skin. Overall, these findings indicate that long-term topical NMN did not protect chronically UVB-exposed mouse skin and may have contributed to the worsening of photodamage.
SN - 1422-0067
ER -